{
  "docId": "019de511-345d-7570-a494-480f2370811c",
  "docSlug": "ec9eb0ed92f9fb3cafb36e44028c44da",
  "documentTitle": "MaxCyte | IPO Presentation Deck | 34 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7843866,
  "pageNumber": 23,
  "pageCount": 34,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "Shows a transition from current beta testing to future ExPERT brand launch.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de511-345d-7570-a494-480f2370811c/23",
  "deckHref": "/decks/019de511-345d-7570-a494-480f2370811c",
  "deckJsonHref": "/decks/019de511-345d-7570-a494-480f2370811c.json",
  "deckAnchorHref": "/decks/019de511-345d-7570-a494-480f2370811c#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.39,
        "y": 0.18
      },
      "kind": "callout",
      "text": "Up to 200 billion cells in < 30 minutes",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0df56535-b429-482d-a33a-96a99a7435ee",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.6,
        "x": 0.25,
        "y": 0.77
      },
      "kind": "list",
      "text": "Recombinant proteins; Viral vector; Virus-like particles (VLPs); Allogeneic cell therapies; Vaccines",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2566d0f4-305a-4707-a1a6-9a569c43819e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.3,
        "x": 0.58,
        "y": 0.32
      },
      "kind": "list",
      "text": "Working towards launching the VLx under the ExPERT brand; Ease-of-use and cell handling improvements; cGMP compliance; GMP consumables",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b2337df-cbb5-4519-910f-c3aed8861bba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.3,
        "x": 0.05,
        "y": 0.36
      },
      "kind": "list",
      "text": "Specifically designed for extremely large volume cell-engineering; Capacity to transfect up to 200 billion cells in less than 30 minutes; In beta testing for large scale bioprocessing applications",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f2d032e6-a6c9-4ddc-ae61-fefebee2a298",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.2,
        "x": 0.15,
        "y": 0.27
      },
      "kind": "paragraph",
      "text": "VLX Instrument",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1a134b93-ce03-4cb9-b274-b50e06f5d77d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.2,
        "x": 0.65,
        "y": 0.27
      },
      "kind": "paragraph",
      "text": "VLx Instrument",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f2b3fca5-57be-4289-8122-a6b8fbf6374a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.5,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "The VLX: Enabling Large Scale Bioprocessing",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0ab49a7b-fffa-4472-8f13-92969ba2ecc6",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "75c5adce-443e-43eb-8473-0157961cca34",
      "evidence": "list/bullet: Specifically designed for extremely large volume cell-engineering",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 23,
      "from": 21,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "74376caf-55e2-48ee-8219-1b80b07b8da2",
      "evidence": "Slides 21-23 discuss competitive analysis and the VLX platform.",
      "position": 1,
      "objective": "The consequences of not using MaxCyte's platform",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}